[PDF] Top 20 Using antimicrobial adjuvant therapy in cancer treatment: a review

... translation. Treatment with the broad spectrum antiviral agent ribavirin was beneficial in poor prognosis acute myeloid leukemia ...in cancer development as vascular endothelial growth factor (VEGF), ... See full document

... considered cancer it is slow growing, does not spread or invade surrounding tissues, and once it is removed, does’t usually ...the cancer cells have spread to the surroundings tissues, even after the ... See full document

... Index Cancer Scale (FLICS), Post-che- motherapy State Anxiety Scale (PCSTAS), and the Rhodes Index of Nausea and Vomiting Form 2, and non-validated tools such as the Chemotherapy Experience survey, and the ... See full document

... photothermal therapy has attracted a lot of interest in the cancer treatment ...of cancer therapy owing to its ability to absorb near-infrared radiation as well as efficient light to ... See full document

... of adjuvant imatinib treat- ment based on available evidence, some agencies rec- ommend adjuvant imatinib ...Comprehensive Cancer Network (NCCN) in the United States recommends adjuvant ... See full document

... the cancer cell by enzymatic ...colorectal cancer has evolved in the last 15 ...the adjuvant setting, the Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial demonstrated that ... See full document

... statistic using a planned cut-off for significance of p < ...dose) using the equation BED = nd (1+d/α/β), where n = number of fractions, d = dose per fraction, and it is assumed that α/β = 10 for tumour ... See full document

... by IHC staining of 2 + or 3 + , rather than by gene amplification. Standard chemotherapy consisted of an anthracycline (doxo- rubicin or epirubicin) plus cyclophosphamide for those patients who had not been exposed to ... See full document

... of adjuvant targeted agents after nephrectomy for patients with high-risk nmRCC: ASSURE[1], S-TRAC[2], PROTECT[3], SORCE[6], EVEREST[7], ATLAS[8] and ARISER[9] (Table ...this review due to its different ... See full document

... Fisher, et al., “Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17,” Journal of Clin[r] ... See full document

... There are several limitations to this review. It was not possible to conduct a meta-analysis due to significant het- erogeneity between studies. This heterogeneity also makes it difficult to compare across studies ... See full document

... Amino acid sequences (peptide) are the building block for peptide vaccine. Antigen stimulates the immune response by recognizing the tumor cell. Epitope based peptide vaccines are upgraded and effective in the ... See full document

... designed using open-ended questions and probes and consisted of questions such as, how oncologists considered adherence to AET; what factors they thought in fl uenced adherence/non-adherence; what were the patients ... See full document

... tumor, treatment modalities (surgery, chemotherapy, radiation and hormone therapy), disease-free survival, and overall survival were obtained by reviewing medical ...on Cancer (AJCC) ...plotted ... See full document

... of Cancer Research [ICR], Sutton; Edinburgh Clinical Trials Unit; and Cancer Research ...of Treatment Study and Other Expe- riences in Solid Tumors); Michelle Collinson (CTRU) and Rog- er A’Hern ... See full document

... Letrozole treatment significantly reduced the risk of distant metastases in both node- negative and -positive patients (P = ...of treatment crossover, demonstrating at a median follow-up of 64 months that ... See full document

... the treatment of various diseases [24, ...after adjuvant therapy with inter- feron, and microvascular density was obviously lower than the control group, and there was significant differ- ... See full document

... for treatment of ...by using probiotics may be useful to CRC risk (Verbeke et ...colorectal cancer (CRC), although some have investigated breast (Veer et ...bladder cancer (Ohashi et ...this ... See full document

... of treatment reduced tumor volume such that 15 patients who, at treatment onset, were considered to require mastectomy, were eligible for breast conserva- tion after 3 ...of treatment (pale ... See full document

... This qualitative study explored factors influencing adherence to AET in women with early-stage breast cancer. Factors that influenced continued adherence included provision of timely expert information about AET, ... See full document